Generics Group Says 'Skinny Label' Suit Should Not Proceed
The Association for Accessible Medicines has urged a Delaware federal judge to reject part of a magistrate judge's report and recommendation not to dismiss Amarin Pharma Inc.'s infringement suit against Hikma...To view the full article, register now.
Already a subscriber? Click here to view full article